Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US…

Overview of attention for article published in Cancer Management and Research, April 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 41 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

HEBIPA, 20 May 2017

Metastatic pancreatic cancer: Nab-P + G is equivalent to FOLFIRINOX